Search results
GLP-1 Discontinuation Less Common With Endocrinologists
Medscape· 6 hours agoPatients taking glucagon-like peptide 1 (GLP-1) receptor agonists for obesity appear to be discontinuing the medications before they can have any meaningful impact on weight ...
Wait—Why Am I Not Losing Weight on Ozempic?
Parade· 48 minutes agoOzempic is technically for the management of type 2 diabetes. The most significant "side effect" of the diabetes drug, weight loss, has made it sought...
Obesity: Does eating chili peppers increase or decrease risk?
Medical News Today· 1 day agoChili peppers are often recognized for their slight fat-burning and metabolism-boosting properties....
What's the Difference Between Ozempic and Metformin, and Which One Is Right for You?
Parade via Yahoo News· 4 days agoOzempic is a GLP-1 medication approved by the FDA for treating Type 2 diabetes. "It is a brand name...
'American Idol' alum Mandisa died from complications of class III obesity. Here's what that means.
Yahoo Life· 5 days agoHowever, an individual’s risk of developing cardiometabolic diseases like hypertension, stroke and ...
Biophytis Announces Filing of an IND Application with the US FDA for its Phase 2 Study in Obesity
Digital Journal· 4 hours agoFood and Drug Administration (FDA) regarding its phase 2 OBA clinical study in obesity with BIO101 (20-hydroxyecdysone). The OBA study will assess the efficacy and safety ...
4 easy ways to meet your takeout cravings while cutting down on ultra-processed foods, according to...
INSIDER via Yahoo News· 2 hours agoYou can avoid the deep-fried fries that fast-food places tend to serve, which are associated with...
The Zacks Analyst Blog Highlights Stocks recently featured in the blog include: Novo Nordisk,...
Zacks via Yahoo Finance· 3 hours agoThe drug is now indicated in the United States to also reduce heart risks, which is a huge boost....
Diabetes drug recommended to treat obesity on the NHS
Press Association News via AOL· 6 days agoThe type 2 diabetes drug Mounjaro has been recommended to help obese people lose weight on the NHS....
Weight-loss injections could halve risk of cancer
The Telegraph via Yahoo News· 6 days agoThe GLP-1 agonist drugs, which are licensed to treat obesity and diabetes, could revolutionise cancer care after studies found they reduced the risk of...